LifeStance Health Group (LFST) had its price target raised by Canaccord Genuity Group Inc. from $9.00 to $10.00. They now have a "buy" rating on the stock.
LifeStance Health Group (LFST) had its price target raised by UBS Group AG from $10.00 to $12.00. They now have a "buy" rating on the stock.
LifeStance Health Group (LFST) had its price target raised by KeyCorp from $8.00 to $9.00. They now have an "overweight" rating on the stock.
LifeStance Health Group Announces Launch of Secondary Public Offering
LifeStance Health Group Inc (LFST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]